Control of nematode parasites with agents acting on neuro-musculature systems: Lessons for neuropeptide ligand discovery

Advances in Experimental Medicine and Biology

Volumn 692, Issue , 2010, Pages 138-154

  Martin, Richard J ^a   Robertson, Alan P ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANTHELMINTIC AGENT; ANTINEMATODAL AGENT; AVERMECTIN; BENZIMIDAZOLE DERIVATIVE; BEPHENIUM; BUTAMISOLE; CHOLINESTERASE; DESOXYPARAHERQUAMIDE; DICHLORVOS; DIETHYLCARBAMAZINE; EMODEPSIDE; IVERMECTIN; LEVAMISOLE; LIGAND; METRIFONATE; MORANTEL; NEUROPEPTIDE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; ORGANOPHOSPHORUS COMPOUND; OXANTEL; PARAHERQUAMIDE; PHENOTHIAZINE; PIPERAZINE; PRAZIQUANTEL; PYRANTEL; THENIUM; UNCLASSIFIED DRUG; UNINDEXED DRUG; NEUROMUSCULAR BLOCKING AGENT;

ARTICLE; CHOLINESTERASE INHIBITION; CROSS RESISTANCE; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG STRUCTURE; FLACCID PARALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; INNATE IMMUNITY; NEMATODE; NEMATODIASIS; NEUROMUSCULAR SYSTEM; NEUROTOXICITY; NONHUMAN; PARASITE CONTROL; PRIORITY JOURNAL; SPASTIC PARESIS; STRUCTURE ANALYSIS; TERATOGENICITY; ANIMAL; DOMESTIC ANIMAL; DRUG EFFECT; HELMINTH; PARASITOLOGY; PATHOGENICITY; PHYSIOLOGY; REVIEW; SWINE;

ANCYLOSTOMATOIDEA; ANIMALIA; ARMERIA; DICTYOCAULUS;

ANIMALS; ANIMALS, DOMESTIC; ANTHELMINTICS; BENZIMIDAZOLES; HELMINTHS; IVERMECTIN; NEMATODA; NEUROMUSCULAR BLOCKING AGENTS; NEUROPEPTIDES; SWINE;

EID: 79952278615     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6902-6_7     Document Type: Article

References (90)

1. Geary TG, Sangster NC and Thompson DP. Frontiers in anthelmintic pharmacology. Vet Parasitol 1999; 84:275-295. (Pubitemid 29320035)
2. Bain RK. Irradiated vaccines for helminth control in livestock. Int J Parasitol 1999; 29:185-191. (Pubitemid 29042260)
3. Albonico M, Bickle Q, Haji HJ et al. Evaluation of the efficacy of pyrantel-oxantel for the treatment of soil-transmitted nematode infections. Trans: Roy Soc Trop Med 2002; 685-690. (Pubitemid 36231498)
4. Reynoldson JA, Behnke JM, Pallant LJ et al. Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. Acta Trop 1997; 68:301-312. (Pubitemid 28041317)
5. Martin RJ. Modes of action of anthelmintic drugs. Vet J 1997; 154:11-34. (Pubitemid 27371230)
6. Kohler P. The biochemical basis of anthelmintic action and resistance. Int J Parasitol 2001; 31:336-345. (Pubitemid 32295900)
7. Robertson AP, Clark CL, Burns TA et al. Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle. J Pharmacol Exp Ther 2002l; 302:853-860.
8. Martin RJ, Bai G, Clark CL et al. Methyridine (2-[2-methoxyethyl]- pyridine]) and levamisole activate different ACh receptor subtypes in nematode parasites: a new lead for levamisole-resistance. Br J Pharmacol 2003; 140:1068-1076. (Pubitemid 37475973)
9. Edwards G, Breckenridge AM. Clinical pharmacokinetics of anthelmintic drugs. Clin Pharmacokinet 1988; 15:67-93.
10. Baggot JD, Mckellar QA. The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. J Vet Pharmacol Ther 1994; 17:409-419.
11. Hennessy DR. Physiology, pharmacology and parasitology. Int J Parasitol 1997; 27:145-152. (Pubitemid 27139705)
12. Martin RJ. Electrophysiological effects of piperazine and diethylcarbamazine on Ascaris suum somatic muscle. Br J Pharmacol 1982; 77:255-265. (Pubitemid 12032132)
13. Martin RJ. gamma-Aminobutyric acid- and piperazine-activated single-channel currents from Ascaris suum body muscle. Br J Pharmacol 1985; 84:445-461. (Pubitemid 15169234)
14. Piper PJ, Temple DM. The effect of lipoxygenase inhibitors and diethylcarbamazine on the immunological release of slow reacting substance of anaphylaxis (SRS-A) from guinea-pig chopped lung. J Pharm Pharmacol 1981; 33:384-386. (Pubitemid 11042909)
15. Roy TK, Sharma S, Srivastava VM. Comparative tissue distribution and urinary excretion of diethylcarbamazine and centperazine. Indian J Med Res 1981; 74:565-571. (Pubitemid 12190141)
16. Lee S, Casteel DA, Fleckenstein L. Specific gas chromatographic analysis of diethylcarbamazine in human plasma using solid-phase extraction. J Chromatogr B Biomed Sci Appl 1997; 704:181-185. (Pubitemid 28021903)
17. Holden-Dye L, Brownlee DJ, Walker RJ. The effects of the peptide KPNFIRFamide (PF4) on the somatic muscle cells of the parasitic nematode Ascaris suum. Br J Pharmacol 1997; 120:379-386. (Pubitemid 27052834)
18. Fellowes RA, Maule AG, Marks NJ et al. Nematode neuropeptide modulation of the vagina vera of Ascaris suum: in vitro effects of PF1, PF2, PF4, AF3 and AF4. Parasitology 2000; 120 (Pt 1):79-89. (Pubitemid 30107726)
19. Purcell J, Robertson AP, Thompson DP et al. PF4, a FMRFamide-related peptide, gates low-conductance Cl(-) channels in Ascaris suum. Eur J Pharmacol 2002; 456:11-17. (Pubitemid 35351731)
20. Qian H, Martin RJ, Robertson AP. Pharmacology of N-, L- and B- subtypes of nematode nAChRresolved and the single channel level. FASEB Journal 2006; 20:E1-E9.
21. Sangster NC, Davis CW, Collins GH et al. Effects of cholinergic drugs on longitudinal contraction in levamisole-susceptible and -resistant Haemonchus contortus Int J Parasitol 1991; 21:689-695.
22. Lee EL, Iyngkaran N, Grieve AW et al. Therapeutic evaluation of oxantel pamoate (1, 4, 5, 6-tetrahydro-1-methyl-2-[trans-3-hydroxystyryl] pyrimidine pamoate) in severe Trichuris trichiura infection. Am J Trop Med Hyg 1976; 25:563-567.
23. Mitchell SC. The toxicity of phenothiazine. Drug Metabol Drug Interact 1994; 11:201-235. (Pubitemid 24237030)
24. Boddie GF. Veterinary Therapeutics Oliver and Boyd 1952; London.
25. Arena JP, Liu KK, Paress PS et al. The mechanism of action of avermectins in Caenorhabditis elegans: correlation between activation of glutamate-sensitive chloride current, membrane binding and biological activity. J Parasitol 1995; 81:286-294.
26. Cully DF, Paress PS, Liu KK et al. Identification of a Drosophila melanogaster glutamate-gated chloride channel sensitive to the antiparasitic agent avermectin. J Biol Chem 1996; 271:20187-20191. (Pubitemid 26281776)
27. Martin RJ, Robertson AP, Wolstenholme AJ. Mode of action of the macrocyclic lactones. ed. Vercruysse J, Rew RS 2002; 125-140. Wallingford: CABI.
28. Steel JW, Waring RH. Ecological Impact of Macrocyclic lactones on Dung Fauna. In Macrocyclic lactones in antiparasitic therapy ed. Vercruysse J, Rew RS 2002; 141-162. Wallingford: CABI.
29. Raymond V, Mongan NP, Sattelle DB. Anthelmintic actions on homomer-forming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans. Neuroscience 2000; 101:785-791.
30. Geary TG, Sims SM, Thomas EM et al. Haemonchus contortus: ivermectin-induced paralysis of the pharynx. Exp Parasitol 1993; 77:88-96. (Pubitemid 23243960)
31. Martin RJ. An electrophysiological preparation of Ascaris suum pharyngeal muscle reveals a glutamate- gated chloride channel sensitive to the avermectin analogue, milbemycin D. Parasitology 1996; 112 ( Pt 2):247-252. (Pubitemid 26069951)
32. Sheriff JC, Kotze AC, Sangster NC et al. Effects of macrocyclic lactone anthelmintics on feeding and pharyngeal pumping in Trichostrongylus colubriformis in vitro. Parasitology 2002; 125:477-484. (Pubitemid 35397385)
33. Gill JH, Kerr CA, Shoop WL et al. Evidence of multiple mechanisms of avermectin resistance in haemonchus contortus-comparison of selection protocols. Int J Parasitol 1998; 28:783-789. (Pubitemid 28266909)
34. Richards JC, Behnke JM, Duce IR. In vitro studies on the relative sensitivity to ivermectin of Necator americanus and Ancylostoma ceylanicum. Int J Parasitol 1995; 25:1185-1191.
35. Geary TG. Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol 2005; 21:530-532. (Pubitemid 41447026)
36. Mckellar QA and Scott EW. The benzimidazole anthelmintic agents-a review. J Vet Pharmacol Ther 1990; 13:223-247.
37. Martin RJ, Robertson AP, Bjorn H. Target sites of anthelmintics. Parasitology 1997; 114 Suppl: S111-S124.
38. Lubega GW, Klein RD, Geary TG et al. Haemonchus contortus: the role of two beta-tubulin gene subfamilies in the resistance to benzimidazole anthelmintics. Biochem Pharmacol 1994; 47:1705-1715. (Pubitemid 24167286)
39. Geary TG, Nulf SC, Exander-Bowman SJ et al. Cloning and characterization of cDNAs encoding beta-tubulin from Dirofilaria immitis and Onchocerca volvulus. J Parasitol 1998; 84:356-360. (Pubitemid 28217414)
40. Gunawan M, Sangster NC, Kelly JD et al. The efficacy of fenbendazole and albendazole against immature and adult stages of benzimidazole-resistant sheep trichostrongylids. Res Vet Sci 1979; 27:111-115. (Pubitemid 9222827)
41. Sangster NC, Prichard RK, Lacey E. Tubulin and benzimidazole-resistance in Trichostrongylus colubriformis (Nematoda). J Parasitol 1985; 71:645-651. (Pubitemid 16234595)
42. Sangster NC, Gill J. Pharmacology of anthelmintic resistance. Parasitol Today 1999; 15:141-146. (Pubitemid 29222700)
43. Von Samson-Himmelstjerna G, Harder A, Sangster NC et al. Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle. Parasitology 2005; 130:343-347. (Pubitemid 40444953)
44. Harder A, Von Samson-Himmelstjerna G. Cyclooctadepsipeptides-a new class of anthelmintically active compounds. Parasitol Res 2002; 88:481-488. (Pubitemid 34810711)
45. Willson J, Amliwala K, Harder A et al. The effect of the anthelmintic emodepside at the neuromuscular junction of the parasitic nematode Ascaris suum. Parasitology 2003; 126:79-86. (Pubitemid 36246202)
46. Davis RE. Action of excitatory amino acids on hypodermis and the motornervous system of Ascaris suum: pharmacological evidence for a glutamate transporter. Parasitology 1998; 116 (Pt 5):487-500. (Pubitemid 28221668)
47. Schaeffer JM, Bergstrom AR, Turner MJ. MK-801 is a potent nematocidal agent. Characterization of MK-801 binding sites in Caenorhabditis elegans. Biochem J 1989; 260:923-926. (Pubitemid 19155689)
48. Schaeffer JM, Bergstrom AR, Frazier EG et al. Nematocidal activity of MK-801 analogs and related drugs. Structure-activity relationships. Biochem Pharmacol 1994; 48:411-418.
49. Ehrlich P, Shiga K. Farbentherapeutische Versuche bei Trypanosomenerkrankung. 1904; 329-392.
50. Browning C. Experimental chemotherapy in Trypanosome Infections. 1907; 1405-1409.
51. Prichard RK. Anthelmintic resistance in nematodes: extent, recent understanding and future directions for control and research. Int J Parasitol 1990; 20:515-523. (Pubitemid 20273988)
52. Waruiru RM, Ngotho JW, Mukiri JG. Multiple anthelmintic resistance in Haemonchus contortus on a sheep farm in Kenya. Vet Res Commun 1997; 21:483-491. (Pubitemid 27432761)
53. Sangster NC, Bannan SC, Weiss AS et al. Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins. Exp Parasitol 1999; 91:250-257.
54. Zajac AM, Gipson TA. Multiple anthelmintic resistance in a goat herd. Vet Parasitol 2000; 87:163-172. (Pubitemid 29516487)
55. Martin PJ, Mckenzie JA. Levamisole resistance in Trichostrongylus colubriformis: a sex-linked recessive character. Int J Parasitol 1990; 20:867-872.
56. Jackson F. Anthelmintic resistance-the state of play. Br Vet J 1993; 149:123-138.
57. Coles GC, Jackson F, Pomroy WE et al. The detection of anthelmintic resistance in nematodes of veterinary importance. Vet Parasitol 2006; 136:167-185. (Pubitemid 43323359)
58. Lacey E, Prichard RK. Interactions of benzimidazoles (BZ) with tubulin from BZ-sensitive and BZ-resistant isolates of Haemonchus contortus. Mol Biochem Parasitol 1986; 19:171-181. (Pubitemid 16076530)
59. Lubega GW, Prichard RK. Beta-tubulin and benzimidazole resistance in the sheep nematode Haemonchus contortus. Mol Biochem Parasitol 1991; 47:129-137.
60. Geary TG, Nulf SC, Favreau MA et al. Three beta-tubulin cDNAs from the parasitic nematode Haemonchus contortus. Mol Biochem Parasitol 1992; 50:295-306.
61. Roos MH, Kwa MS, Veenstra JG et al. Molecular aspects of drug resistance in parasitic helminths. Pharmacol Ther 1993; 60:331-336. (Pubitemid 24117383)
62. Blackhall WJ, Liu HY, Xu M et al. Selection at a P-glycoprotein gene in ivermectin- and moxidectinselected strains of Haemonchus contortus. Mol Biochem Parasitol 1998a; 95:193-201. (Pubitemid 29027842)
63. Blackhall WJ, Pouliot JF, Prichard RK et al. Haemonchus contortus: selection at a glutamate-gated chloride channel gene in ivermectin- and moxidectin-selected strains. Exp Parasitol 1998b; 90:42-48. (Pubitemid 28406685)
64. Dent JA, Smith MM, Vassilatis DK et al. The genetics of ivermectin resistance in Caenorhabditis elegans. Proc Natl Acad Sci. USA 2000; 97:2674-2679. (Pubitemid 30159230)
65. Wolstenholme AJ, Fairweather I, Prichard R. Drug resistance in veterinary helminths. Trends Parasitol 2004; 20:469-476. (Pubitemid 39195056)
66. Van DV, De VE. A single nucleotide polymorphism map of the mitochondrial genome of the parasitic nematode Cooperia oncophora. Parasitology 2004; 128:421-431.
67. Hoglund J, Engstrom A, Morrison DA et al. Genetic diversity assessed by amplified fragment length polymorphism analysis of the parasitic nematode Dictyocaulus viviparus the lungworm of cattle. Int J Parasitol 2004; 34:475-484. (Pubitemid 38317171)
68. Eng JK, Prichard RK. A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients. Mol Biochem Parasitol 2005; 142:193-202. (Pubitemid 40835911)
69. Hoglund J, Morrison DA, Mattsson JG et al. Population genetics of the bovine/cattle lungworm (Dictyocaulus viviparus) based on mtDNA and AFLP marker techniques. Parasitology 2006; 133:89-99. (Pubitemid 43886441)
70. Kaplan RM, Burke JM, Terrill TH et al. Validation of the FAMACHA eye color chart for detecting clinical anemia in sheep and goats on farms in the southern United States. Vet Parasitol 2004; 123:105-120. (Pubitemid 38950896)
71. Martin RJ, Murray I, Robertson AP et al. Anthelmintics and ion-channels: after a puncture, use a patch. Int J Parasitol 1998; 28:849-862. (Pubitemid 28298959)
72. Greenwood K, Williams T, Geary T. Nematode neuropeptide receptors and their development as anthelmintic screens. Parasitology 2005; 131 Suppl: S169-S177.
73. Jones AK, Sattelle DB. Functional genomics of the nicotinic acetylcholine receptor gene family of the nematode. Caenorhabditis elegans Bioessays 2004; 26:39-49. (Pubitemid 38095347)
74. Yew JY, Kutz KK, Dikler S. Mass spectrometric map of neuropeptide expression in Ascaris suum. J Comp Neurol 2005; 488:396-413. (Pubitemid 40934679)
75. Mousley A, Maule AG, Halton DW et al. Inter-phyla studies on neuropeptides: the potential for broad-spectrum anthelmintic and/or endectocide discovery. Parasitology 2005; 131 Suppl: S143-S167.
76. Mousley A, Marks NJ, Halton DW et al. Arthropod FMRFamide-related peptides modulate muscle activity in helminths. Int J Parasitol 2004; 34:755-768. (Pubitemid 38521230)
77. Kamath RS, Fraser AG, Dong Y et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003; 421:231-237. (Pubitemid 36139121)
78. Keating CD, Kriek N, Daniels M et al. Whole-genome analysis of 60 G protein-coupled receptors in Caenorhabditis elegans by gene knockout with RNAi Curr Biol 2003; 13:1715-1720.
79. Maule AG, Bowman JW, Thompson DP et al. FMRFamide-related peptides (FaRPs) in nematodes: occurrence and neuromuscular physiology. Parasitology 1996; 113 Suppl: S119-S135. (Pubitemid 27095161)
80. Maule AG, Mousley A, Marks NJ et al. Neuropeptide signaling systems-potential drug targets for parasite and pest control. Curr Top Med Chem 2002; 2:733-758.
81. Geary TG, Conder GA, Bishop B. The changing landscape of antiparasitic drug discovery for veterinary medicine. Trends Parasitol 2004; 20:449-455. (Pubitemid 39195053)
82. Stables J, Green A, Marshall F et al. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem 1997; 252:115-126. (Pubitemid 27408700)
83. Geary TG, Kubiak TM. Neuropeptide G-protein-coupled receptors, their cognate ligands and behavior in Caenorhabditis elegans. Trends Pharmacol Sci 2005; 26:56-58. (Pubitemid 40170165)
84. Mckellar QA. Ecotoxicolog y and residues of anthelmintic compounds. Vet Parasitol 1997; 72:413-426.
85. Dipietro JA, Todd KS, JR. Anthelmintics used in treatment of parasitic infections of horses. Vet Clin North Am. Equine Pract 1987; 3:1-14.
86. Hopper K, Aldrich J, Haskins S.C. Ivermectin toxicity in 17 collies. J Vet Intern Med 2002; 16:89-94. (Pubitemid 135746928)
87. Nelson OL, Carsten E, Bentjen SA et al. Ivermectin toxicity in an Australian Shepherd dog with the MDR1 mutation associated with ivermectin sensitivity in Collies. J Vet Intern Med 2003; 17:354-356. (Pubitemid 37465339)
88. Seaman JT, Eagleson JS, Carrigan MJ et al. Avermectin B1 toxicity in a herd of Murray Grey cattle. Aust Vet J 1989; 64:284-285.
89. Whittaker SG, Faustman EM. Effects of albendazole and albendazole sulfoxide on cultures of differentiating rodent embryonic cells. Toxicol Appl Pharmacol 1991; 109:73-84.
90. Capece BP, Navarro M, Arcalis T et al. Albendazole sulphoxide enantiomers in pregnant rats' embryo concentrations and developmental toxicity. Vet J 2003; 165:266-275. (Pubitemid 37555006)